멀티 도스 점안기 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Multi-Dose Eye Dropper was estimated to be worth US$ 569 million in 2024 and is forecast to a readjusted size of US$ 1806 million by 2031 with a CAGR of 18.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Multi-Dose Eye Dropper cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Multi-Dose Eye Dropper is a kind of medical devices, which is used to treat major eye problems and diseases for patients especially the elderly person. Conventional Multidose systems are the so called "Three-Piece-Droppers", where preservatives are added to the dosing systems to reduce microbial contamination and growth in the product during use and storage. Preservatives though are best avoided since they can damage the ocular surface when used on a frequent basis, hence a device without the need of a preserving agent is highly recommended. The report only considers the preservative-free Multidose eyedropper device/system,which is based on pump or other mechanism.

As an important carrier for ophthalmic drug packaging, multi-dose eye droppers are becoming a key direction to replace single-dose packaging with their high efficiency, economy and environmental friendliness. The current market can be subdivided into less than 5 ml, 5-10 ml, 10-30 ml and other specifications according to capacity. Among them, 5-10 ml products occupy a mainstream position in the prescription and over-the-counter (OTC) markets because they can meet the needs of general treatment and are easy to carry and store. Prescription applications are mainly concentrated in the long-term treatment of chronic diseases such as glaucoma, dry eyes, and allergic conjunctivitis, while the over-the-counter market covers daily care needs such as eye fatigue, moisturizing, and antibacterial. The consumer population is wide, especially in emerging markets such as Asia Pacific and the Middle East. The growth rate is significant.

The core manufacturers of multi-dose eye drops in the world include Aptar Group, Aero Pump GmbH and Nemera. The top three manufacturers account for about 70% of the global market share. The global production areas are mainly distributed in North America, Europe, China, India, etc. Europe has the largest sales market, with a market share of more than 55%; followed by North America. In terms of product type, less than 5 ml is the largest segment, accounting for about 39% of the share. At the same time, in terms of downstream, prescription drugs are the largest downstream field, accounting for 86% of the share.

As the global population aging trend intensifies, the prevalence of eye diseases continues to rise, and people's awareness of eye health care increases, the market demand for multi-dose eye drops is growing. At the same time, the demand for "preservative-free eye drops" is becoming more and more urgent, which forces packaging companies to develop aseptic valve systems, anti-reflux structures, intelligent dosage control and other technologies to avoid the risk of infection caused by secondary contamination in traditional multi-dose packaging during long-term use. Under the pressure of sustainable development, environmental innovations such as recyclable materials and biodegradable plastics have also become the focus of competition.

For manufacturers, product technical barriers should be improved from the dimensions of material safety, sealing structure accuracy, aseptic filling adaptability, etc., especially in-depth cooperation with pharmaceutical companies to achieve collaborative design of drugs and packaging. In addition, building a production system that complies with regulatory standards such as FDA, EMA, and NMPA, as well as developing modular product lines for different capacity segments and indications, will help companies achieve breakthroughs in both high-end medical devices and mass consumer products. In the future, multi-dose eye drops will not only be drug containers, but will also evolve into smart, environmentally friendly, and patient-friendly "treatment interaction terminals."

This report aims to provide a comprehensive presentation of the global market for Multi-Dose Eye Dropper, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Multi-Dose Eye Dropper by region & country, by Type, and by Application.

The Multi-Dose Eye Dropper market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-Dose Eye Dropper.

Market Segmentation

By Company

• AptarGroup
• Aero Pump GmbH
• Nemera
• Ursapharm Arzneimittel GmbH
• Laboratoires Thea
• Silgan Dispensing Systems
• Gaplast GmbH
• Berry Global

Segment by Type

• Less than 5 ml
• 5 ml-10 ml
• 10ml-30 ml
• Others

Segment by Application

• Prescription
• Over-The-Counter

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Multi-Dose Eye Dropper manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Multi-Dose Eye Dropper in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Multi-Dose Eye Dropper in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Multi-Dose Eye Dropper Product Introduction
• 1.2 Global Multi-Dose Eye Dropper Market Size Forecast
  • 1.2.1 Global Multi-Dose Eye Dropper Sales Value (2020-2031)
  • 1.2.2 Global Multi-Dose Eye Dropper Sales Volume (2020-2031)
  • 1.2.3 Global Multi-Dose Eye Dropper Sales Price (2020-2031)
• 1.3 Multi-Dose Eye Dropper Market Trends & Drivers
  • 1.3.1 Multi-Dose Eye Dropper Industry Trends
  • 1.3.2 Multi-Dose Eye Dropper Market Drivers & Opportunity
  • 1.3.3 Multi-Dose Eye Dropper Market Challenges
  • 1.3.4 Multi-Dose Eye Dropper Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Multi-Dose Eye Dropper Players Revenue Ranking (2024)
• 2.2 Global Multi-Dose Eye Dropper Revenue by Company (2020-2025)
• 2.3 Global Multi-Dose Eye Dropper Players Sales Volume Ranking (2024)
• 2.4 Global Multi-Dose Eye Dropper Sales Volume by Company Players (2020-2025)
• 2.5 Global Multi-Dose Eye Dropper Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Multi-Dose Eye Dropper Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Multi-Dose Eye Dropper Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Multi-Dose Eye Dropper
• 2.9 Multi-Dose Eye Dropper Market Competitive Analysis
  • 2.9.1 Multi-Dose Eye Dropper Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Multi-Dose Eye Dropper Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-Dose Eye Dropper as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Less than 5 ml
  • 3.1.2 5 ml-10 ml
  • 3.1.3 10ml-30 ml
  • 3.1.4 Others
• 3.2 Global Multi-Dose Eye Dropper Sales Value by Type
  • 3.2.1 Global Multi-Dose Eye Dropper Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Multi-Dose Eye Dropper Sales Value, by Type (2020-2031)
  • 3.2.3 Global Multi-Dose Eye Dropper Sales Value, by Type (%) (2020-2031)
• 3.3 Global Multi-Dose Eye Dropper Sales Volume by Type
  • 3.3.1 Global Multi-Dose Eye Dropper Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Multi-Dose Eye Dropper Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Multi-Dose Eye Dropper Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Multi-Dose Eye Dropper Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Prescription
  • 4.1.2 Over-The-Counter
• 4.2 Global Multi-Dose Eye Dropper Sales Value by Application
  • 4.2.1 Global Multi-Dose Eye Dropper Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Multi-Dose Eye Dropper Sales Value, by Application (2020-2031)
  • 4.2.3 Global Multi-Dose Eye Dropper Sales Value, by Application (%) (2020-2031)
• 4.3 Global Multi-Dose Eye Dropper Sales Volume by Application
  • 4.3.1 Global Multi-Dose Eye Dropper Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Multi-Dose Eye Dropper Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Multi-Dose Eye Dropper Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Multi-Dose Eye Dropper Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Multi-Dose Eye Dropper Sales Value by Region
  • 5.1.1 Global Multi-Dose Eye Dropper Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Multi-Dose Eye Dropper Sales Value by Region (2020-2025)
  • 5.1.3 Global Multi-Dose Eye Dropper Sales Value by Region (2026-2031)
  • 5.1.4 Global Multi-Dose Eye Dropper Sales Value by Region (%), (2020-2031)
• 5.2 Global Multi-Dose Eye Dropper Sales Volume by Region
  • 5.2.1 Global Multi-Dose Eye Dropper Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Multi-Dose Eye Dropper Sales Volume by Region (2020-2025)
  • 5.2.3 Global Multi-Dose Eye Dropper Sales Volume by Region (2026-2031)
  • 5.2.4 Global Multi-Dose Eye Dropper Sales Volume by Region (%), (2020-2031)
• 5.3 Global Multi-Dose Eye Dropper Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 5.4.2 North America Multi-Dose Eye Dropper Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 5.5.2 Europe Multi-Dose Eye Dropper Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Multi-Dose Eye Dropper Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 5.7.2 South America Multi-Dose Eye Dropper Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Multi-Dose Eye Dropper Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Multi-Dose Eye Dropper Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Multi-Dose Eye Dropper Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Multi-Dose Eye Dropper Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.3.2 United States Multi-Dose Eye Dropper Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Multi-Dose Eye Dropper Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.4.2 Europe Multi-Dose Eye Dropper Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Multi-Dose Eye Dropper Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.5.2 China Multi-Dose Eye Dropper Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Multi-Dose Eye Dropper Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.6.2 Japan Multi-Dose Eye Dropper Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Multi-Dose Eye Dropper Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.7.2 South Korea Multi-Dose Eye Dropper Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Multi-Dose Eye Dropper Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Multi-Dose Eye Dropper Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Multi-Dose Eye Dropper Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Multi-Dose Eye Dropper Sales Value, 2020-2031
  • 6.9.2 India Multi-Dose Eye Dropper Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Multi-Dose Eye Dropper Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 AptarGroup
  • 7.1.1 AptarGroup Company Information
  • 7.1.2 AptarGroup Introduction and Business Overview
  • 7.1.3 AptarGroup Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 AptarGroup Multi-Dose Eye Dropper Product Offerings
  • 7.1.5 AptarGroup Recent Development
• 7.2 Aero Pump GmbH
  • 7.2.1 Aero Pump GmbH Company Information
  • 7.2.2 Aero Pump GmbH Introduction and Business Overview
  • 7.2.3 Aero Pump GmbH Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Aero Pump GmbH Multi-Dose Eye Dropper Product Offerings
  • 7.2.5 Aero Pump GmbH Recent Development
• 7.3 Nemera
  • 7.3.1 Nemera Company Information
  • 7.3.2 Nemera Introduction and Business Overview
  • 7.3.3 Nemera Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Nemera Multi-Dose Eye Dropper Product Offerings
  • 7.3.5 Nemera Recent Development
• 7.4 Ursapharm Arzneimittel GmbH
  • 7.4.1 Ursapharm Arzneimittel GmbH Company Information
  • 7.4.2 Ursapharm Arzneimittel GmbH Introduction and Business Overview
  • 7.4.3 Ursapharm Arzneimittel GmbH Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Ursapharm Arzneimittel GmbH Multi-Dose Eye Dropper Product Offerings
  • 7.4.5 Ursapharm Arzneimittel GmbH Recent Development
• 7.5 Laboratoires Thea
  • 7.5.1 Laboratoires Thea Company Information
  • 7.5.2 Laboratoires Thea Introduction and Business Overview
  • 7.5.3 Laboratoires Thea Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Laboratoires Thea Multi-Dose Eye Dropper Product Offerings
  • 7.5.5 Laboratoires Thea Recent Development
• 7.6 Silgan Dispensing Systems
  • 7.6.1 Silgan Dispensing Systems Company Information
  • 7.6.2 Silgan Dispensing Systems Introduction and Business Overview
  • 7.6.3 Silgan Dispensing Systems Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Silgan Dispensing Systems Multi-Dose Eye Dropper Product Offerings
  • 7.6.5 Silgan Dispensing Systems Recent Development
• 7.7 Gaplast GmbH
  • 7.7.1 Gaplast GmbH Company Information
  • 7.7.2 Gaplast GmbH Introduction and Business Overview
  • 7.7.3 Gaplast GmbH Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Gaplast GmbH Multi-Dose Eye Dropper Product Offerings
  • 7.7.5 Gaplast GmbH Recent Development
• 7.8 Berry Global
  • 7.8.1 Berry Global Company Information
  • 7.8.2 Berry Global Introduction and Business Overview
  • 7.8.3 Berry Global Multi-Dose Eye Dropper Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Berry Global Multi-Dose Eye Dropper Product Offerings
  • 7.8.5 Berry Global Recent Development

8 Industry Chain Analysis

• 8.1 Multi-Dose Eye Dropper Industrial Chain
• 8.2 Multi-Dose Eye Dropper Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Multi-Dose Eye Dropper Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Multi-Dose Eye Dropper Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer